- Investing Ideas
- Indian Pharmaceuticals & Biotech Healthy potentially undervalued
Indian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
2
1 new
Companies which are potentially undervalued and in an acceptable financial position.
2 companies
Alembic Pharmaceuticals
Market Cap: ₹156.8b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹814.45
7D
-3.3%
1Y
-18.6%
Dr. Reddy's Laboratories
Market Cap: ₹960.1b
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
New
500124
₹1,150.90
7D
-5.9%
1Y
-10.5%